Shandong Xinhua Pharmaceutical Co Ltd (000756) — Capital Reinvestment Ratio
Shandong Xinhua Pharmaceutical Co Ltd (000756) has a Capital Reinvestment Ratio of 1.44x as of September 2023, meaning it reinvests 1% of its operating cash flow (CN¥56.11 Million) in capital expenditures (CN¥80.69 Million). Check Shandong Xinhua Pharmaceutical Co Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Xinhua Pharmaceutical Co Ltd Capital Reinvestment Ratio (2015–2024)
This chart tracks Shandong Xinhua Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see 000756 operating cash flow.
Annual Capital Reinvestment Ratio for Shandong Xinhua Pharmaceutical Co Ltd (2015–2024)
Year-by-year Capital Reinvestment Ratio for Shandong Xinhua Pharmaceutical Co Ltd from 2015 to 2024. See Shandong Xinhua Pharmaceutical Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.58x | CN¥367.61 Million | CN¥212.42 Million | ▼ -52.9% |
| 2023 | 1.23x | CN¥265.28 Million | CN¥325.13 Million | ▲ +279.7% |
| 2022 | 0.32x | CN¥758.24 Million | CN¥244.76 Million | ▼ -66.4% |
| 2021 | 0.96x | CN¥259.12 Million | CN¥249.23 Million | ▲ +44.2% |
| 2020 | 0.67x | CN¥420.19 Million | CN¥280.19 Million | ▼ -36.6% |
| 2019 | 1.05x | CN¥348.27 Million | CN¥366.51 Million | ▼ -12.2% |
| 2018 | 1.20x | CN¥323.91 Million | CN¥388.44 Million | ▲ +79.1% |
| 2017 | 0.67x | CN¥389.97 Million | CN¥261.11 Million | ▲ +29.6% |
| 2016 | 0.52x | CN¥439.35 Million | CN¥227.07 Million | ▲ +6.6% |
| 2015 | 0.48x | CN¥348.64 Million | CN¥169.09 Million | — |